Menu
GeneBe

PSMA4

proteasome 20S subunit alpha 4, the group of Proteasome

Basic information

Region (hg38): 15:78540404-78552417

Links

ENSG00000041357NCBI:5685OMIM:176846HGNC:9533Uniprot:P25789AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PSMA4 gene.

  • Inborn genetic diseases (5 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSMA4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
5
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 5 0 1

Variants in PSMA4

This is a list of pathogenic ClinVar variants found in the PSMA4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-78544258-T-G not specified Uncertain significance (Jul 19, 2022)2302401
15-78544920-G-A Benign (Nov 03, 2018)778997
15-78545760-G-A not specified Uncertain significance (Oct 26, 2022)2320846
15-78546641-T-G not specified Uncertain significance (Feb 28, 2023)2490495
15-78548856-T-C not specified Uncertain significance (Nov 18, 2023)3220347
15-78548873-A-C not specified Uncertain significance (May 22, 2023)2519757
15-78548882-G-A not specified Uncertain significance (Jun 27, 2022)2297720

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PSMA4protein_codingprotein_codingENST00000044462 88858
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6000.400125717051257220.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.44571380.4140.000006871704
Missense in Polyphen1358.3530.22278711
Synonymous0.7953844.80.8490.00000211462
Loss of Function2.99315.90.1897.31e-7208

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001200.000120
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002690.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). {ECO:0000269|PubMed:15244466, ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}.;
Pathway
Proteasome - Homo sapiens (human);Proteasome Degradation;Exercise-induced Circadian Regulation;TLR NFkB;proteasome complex;B cell receptor signaling;Post-translational protein modification;Metabolism of proteins;DroToll-like;Notch;Hedgehog;IL-1 NFkB;IL-1 p38;IL-1 JNK;TGF-beta super family signaling pathway canonical;TLR p38;UCH proteinases;Neddylation;Ub-specific processing proteases;JAK STAT pathway and regulation;Deubiquitination;TLR JNK;TNF;Wnt Canonical;Wnt Mammals;CD4 T cell receptor signaling-NFkB cascade;CD4 T cell receptor signaling (Consensus)

Recessive Scores

pRec
0.388

Intolerance Scores

loftool
0.388
rvis_EVS
-0.1
rvis_percentile_EVS
46.2

Haploinsufficiency Scores

pHI
0.969
hipred
Y
hipred_score
0.783
ghis
0.702

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.792

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Psma4
Phenotype

Gene ontology

Biological process
proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;viral process;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification
Cellular component
proteasome complex;P-body;nucleus;nucleoplasm;cytoplasm;cytosol;proteasome core complex;proteasome core complex, alpha-subunit complex;intracellular membrane-bounded organelle;extracellular exosome
Molecular function
endopeptidase activity;threonine-type endopeptidase activity;protein binding